Consider a fermentation time-course: dissolved oxygen drifts downward, pH changes, and biomass plateaus earlier than expected. A scientist may suspect an oxygen-transfer limitation, a media effect, or a strain-specific metabolic response. The sensors alone do not identify the cause.
A historian with comparable past runs could help distinguish those hypotheses. That is an attractive use of machine learning in bioprocess development,not because a model knows biochemistry better than the team, but because it can organize multivariate patterns for scientists to test.
This is a conceptual example. It does not describe a measured result from a McIntosh Consulting engagement.
The gap between process data and a useful conclusion
Bioprocess development produces heterogeneous information: dissolved oxygen, temperature, pH, agitation, feed rates, off-gas composition, biomass estimates, assays, strain histories, and raw-material lots. The measurements are not all continuous or equally trustworthy. Data from a benchtop experiment may have different sampling intervals and sensor behavior from data collected during a pilot run.
Design of Experiments remains a valuable method for estimating effects under a controlled plan. Statistical learning adds a complementary capability: finding candidate nonlinear relationships in existing operational data. Neither method automatically identifies a causal mechanism. A historical association can reflect a confounding change in operator practice, instrumentation, or raw-material sourcing.
A 2024 review of machine learning across biopharmaceutical development and manufacturing discusses applications and the accompanying challenges of process data. It supports treating ML as a potentially useful analytical approach, not as proof that any particular fermentation will improve.
Three useful questions for a model
Is this run departing from its expected trajectory? A simple multivariate statistical model may flag a combination of signals that falls outside patterns seen in comparable reference batches. Its practical value depends on missed-event rates, false alarms, data drift, and whether the reference batches are representative. An anomaly flag is a reason to investigate, not a diagnosis.
Which historical variables deserve another experiment? Imagine a random-forest model trained on suitable fermentation histories finding that an early respiratory-quotient feature correlates with final titer. That is a hypothetical predictor, not a published model or a measured consulting outcome. Respiratory quotient can be biologically informative, but a correlation would still need leakage checks, held-out validation across runs, and an experiment that tests the proposed mechanism.
What carries over to a new scale? Some physiological relationships may remain useful; mixing, mass transfer, gradients, and sensor response often change. A model trained at two liters cannot be assumed accurate at two hundred liters. The value is in identifying what should be retested at the next scale, not pretending the scale-up problem is solved.
The connection to metabolic flux analysis
The analogy with ^13C metabolic flux analysis is instructive. Isotopic measurements and a stoichiometric network constrain estimates of otherwise unobserved intracellular fluxes. A statistical soft sensor instead estimates a process property from available measurements and historical examples.
Those methods answer different questions. A mechanistic model encodes conservation and biochemical assumptions. A data-driven model may represent empirical relationships that are difficult to specify analytically. Hybrid approaches can be useful when both sets of assumptions are exposed and evaluated.
That combination is an active research area. The 2024 roadmap for model-based bioprocess development reviews hybrid modeling and soft sensors; it does not make a new model automatically suitable for a specific production facility.
From monitoring to decision support
Before fitting a sophisticated model, the data need context: strain and construct identifiers, assay methods, calibration histories, media lots, vessel configuration, run phase, and interventions. Missing metadata can make superficially similar fermentations unsuitable for joint training.
An initial model might produce an annotated deviation report that a process scientist reviews. A second step might compare held-out predictions with observed outcomes and quantify where the model fails. If the evidence supports it, the system could recommend follow-up sampling or experiments.
Automated process control is a different undertaking. Closed-loop adjustment of feed, aeration, or other operating parameters requires plant-specific control engineering, safety analysis, validation, operator oversight, and the applicable quality systems. A 2026 NIST conceptual framework for biomanufacturing digital twins and process analytical technology underscores the interoperability and control architecture involved. It is not evidence that a hypothetical titer predictor has been tested as an autonomous controller.
McIntosh Consulting’s role here is analytical decision support: data organization, model comparison, documented uncertainty, and reviewable recommendations. Engineering control design and production decisions remain with qualified facility teams.
What makes it valuable
A useful bioprocess model need not be enormous. It needs to address an identified decision, beat an appropriate baseline, remain interpretable enough to challenge, and fail in ways operators can detect.
The ambition is not to have fermentation data “tell” the team what to do. It is to make the evidence in those data available early enough that scientists can ask better questions and choose better experiments.